Ampicillin dosing in premature infants for early-onset sepsis: exposure-driven efficacy, safety, and stewardship.
Journal Article (Journal Article)
OBJECTIVE: Define optimal ampicillin dosing for empiric early-onset sepsis (EOS) therapy in preterm neonates. STUDY DESIGN: We simulated ampicillin concentrations in newborns (birthweight < 1500 g; gestational age 22-27 weeks), summarizing three 48 h regimens: high 100 mg/kg Q8hr, medium 100 mg/kg Q12hr, and standard 50 mg/kg Q12hr. Concentration data were analyzed for concentration above minimum inhibitory concentration (MIC), below neurotoxicity threshold (Cmax ≤ 140 mcg/mL), and duration limited to 48 h. RESULTS: Among 34,689 newborns, all dosing regimens provided concentrations above MIC through 48 h, but Cmax exceeded the neurotoxicity threshold. With the 4-dose standard regimen, >90% maintained concentrations >MIC beyond 48 h. With the 2-dose regimen, newborns maintained the mean concentration >MIC within the 48 h culture window and below neurotoxicity level. Infants 22-24 weeks' gestation had higher drug concentrations and more prolonged exposure duration than 25-27 weeks' gestation. CONCLUSIONS: For EOS in preterm infants, two ampicillin doses (50 mg/kg) provided optimal bactericidal exposures, while minimizing potential toxicity.
Full Text
Duke Authors
- Benjamin Jr., Daniel Kelly
- Cohen-Wolkowiez, Michael
- Greenberg, Rachel Gottron
- Zimmerman, Kanecia Obie
Cited Authors
- Le, J; Greenberg, RG; Yoo, Y; Clark, RH; Benjamin, DK; Zimmerman, KO; Cohen-Wolkowiez, M; Wade, KC; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee,
Published Date
- July 2022
Published In
Volume / Issue
- 42 / 7
Start / End Page
- 959 - 964
PubMed ID
- 35210541
Pubmed Central ID
- PMC9262754
Electronic International Standard Serial Number (EISSN)
- 1476-5543
Digital Object Identifier (DOI)
- 10.1038/s41372-022-01344-2
Language
- eng
Conference Location
- United States